This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Innovative and adaptive strategies for new drug development are needed to maximize the potential of cell and gene therapies. CRA’s Lev Gerlovin, Walter Colasante, and Pascale Diesel explain in this Cell and Gene article. Click here to read the article.
Potentially curative cell and gene therapies represent a key shift in patient care and will have considerable impact across the patient journey, affecting the...
Lorenzo D’Angelo was interviewed in PharmaPhorum regarding the challenges companies face in getting digital health technologies (DHT) reimbursed. Lorenzo...
CRA is proud to support the New England region of the LLS Man & Woman of the year campaign, a philanthropic competition to support blood cancer research. Ned...
Anthony Barron is moderating an “Issue Panel” on Comprehensive Genomic Profiling (CGP). For more information on this event, click here.
